Outsourced Drug Development Solutions
-
Dynamic And Ergonomic Oligosynthesis Column
5/6/2024
These patented synthesis columns offer oligonucleotide manufacturers a system designed for efficiency and safety.
-
Inverted Microscope Solution- DMi8 S
6/27/2023
Find the missing links
The modular DMi8 inverted microscope is the heart of the DMi8 S platform solution. For routine to live cell research, the DMi8 S platform is a complete solution. Whether you need to precisely follow the development of a single cell in a dish, screen through multiple assays, obtain single molecule resolution, or tease out behaviors of complex processes, a DMi8 S system will enable you to see more, see faster, and find the hidden.
- See more – Increase your viewing area up to 10,000x
- See faster – Experiments up to 5x faster
- See the hidden – Activate, ablate, and bleach within one experiment
-
Pre-Formulation And Material Sciences
3/3/2022
Our formulation development and material sciences experts have over 30 years’ experience in pre-formulation and solid state characterization.
-
Integrated Programs To Bridge Molecules From Discovery Into Clinical Development
1/4/2023
A new collaboration helps to remove obstacles from the critical path, reduce development risks, eliminate the white space in pre-clinical drug development, and shorten the pathway to clinical development.
-
Serum-Free, Xeno-Free Systems For Culture And Differentiation Of hMSCs
8/30/2022
Sartorius offers a novel serum-free (SF) and xeno-free (XF) culture system as well as MSC NutriStem® media, which enable long-term growth of hMSCs from various sources while retaining self-renewal and multi-lineage differentiation potential.
-
Used Elizabeth Hata Pharmaceutical 10 Station Tablet Press
10/3/2023
Used Elizabeth Hata R&D tablet press, model EP200, B/D tooled with 10 station turret, 5 stations each B and D, 16 mm B, 22 mm D max tablet diameter, 17 mm B, 18 mm D max depth of fill, rated up to 6000 tablets/hour, with feed hoppers and feed frames, Machine #81, built 2011.
-
API Stability Combined With Rapid Disintegration
4/2/2025
Enhance tablet effectiveness across various dosages with an excipient that offers excellent compressibility and stability for APIs, which eliminates the need for intense processing and provides rapid disintegration.
-
Where Expertise Meets Simplicity: BD PartnerPath™ Program
8/12/2021
The commercialization of a combination product can be a complex process that involves obtaining the proper data, choosing a drug delivery system, developing a regulatory strategy and conducting clinical trials—all of which can increase development risks and affect your molecule’s time to market.
-
Aragen's Preclinical Oncology Capabilities
3/27/2025
We provide specialized in vivo pharmacology services, offering customized solutions to support the development of immune-oncology therapies from discovery to commercialization.
-
Comprehensive Charge Variant Analysis Made Simple With Intabio ZT System
9/6/2023
The Intabio ZT system couples icIEF separation and UV detection with high resolution mass spectrometry on the ZenoTOF 7600 system.